IDEXX Laboratories, Inc. IDXX

519.26 5.87 1.14% as of 25 Sep

Follow IDXX

S&P 500 Member Cash Flow Champion (3y)

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE	74.21%	72.92%	66.20%	64.63%	+8 more TTM periods Free account
ROA	33.65%	33.19%	31.89%	30.50%
ROIC	48.87%	48.68%	45.33%	43.47%
Return on Tangible Assets	119.33%	122.43%	104.65%	106.50%
Average Days of Receivables	50.27	49.55	46.85	49.65
Free Cash Flow per Share	15.67	13.28	11.89	10.78
Free Cash Flow	1,237.09	1,058.11	956.58	863.22
Capital Expenditures	(134.42)	(151.98)	(225.23)	(224.85)
Piotroski F-Score	8.00	7.00	7.00	7.00
Other line items
Cash ROIC	60.70%	54.84%	52.87%	47.43%
Accounts Receivable Turnover	7.67	7.86	8.39	7.73
Accounts Payable Turnover	13.92	13.49	14.64	13.70
Inventory Turnover	4.36	4.34	4.33	4.08
Average Days of Payables	27.56	28.12	24.51	27.97
Days of Inventory on Hand	83.59	82.73	83.86	89.59
Tax Rate	(0.20)	(0.20)	(0.20)	(0.19)
Research and Development Expense of Revenue	5.74%	5.80%	5.84%	5.81%
Selling, General and Administrative Expense of Revenue	24.67%	24.63%	24.36%	24.57%
Share Based Compensation of Revenue	1.38%	1.39%	1.39%	1.40%
Interest Coverage	0.00	0.00	0.00	0.00
Operating CF/Net income	1.20	1.10	1.12	1.06
Depreciation/Fixed assets	0.21	0.20	0.19	0.19
Capex/Depreciation	(0.87)	(1.02)	(1.55)	(1.60)
Revenue per Share	57.67	55.82	53.51	52.03
Operating CF per Share	17.37	15.19	14.69	13.58
Capex per Share	(1.70)	(1.91)	(2.80)	(2.81)
Capex to Sales	0.03	0.03	0.05	0.05
Net Profit Margin	25.03%	24.63%	24.62%	24.65%

Columns are period end dates

Powerpack